Centenarian’s 100th birthday

A centenarian blows out her 100th birthday candles. (Photo by Dan Negureanu on Shutterstock)

In A Nutshell

  • Centenarians in Sweden developed fewer diseases, later in life, compared to peers who died younger.
  • At age 85, they averaged 1.2 diseases versus 2.4 in those dying at 90.
  • Heart and brain conditions showed the largest health differences; cancers were less common overall but a bigger share of total illness in centenarians.
  • Disease build-up stabilized in centenarians’ final years, while it kept rising for others.

STOCKHOLM — Turning 100 used to conjure images of decades spent juggling multiple health problems and endless doctor visits. But a nationwide study of 274,108 Swedes suggests a different story: those who reach triple digits tend to follow a very different health trajectory.

Rather than simply enduring more illness over a longer period, centenarians tend to develop fewer diseases, accumulate them more slowly, and often see that build-up stabilize late in life. The findings are based on associations, as the study does not prove cause and effect, but they suggest that longevity may be linked to resilience against certain conditions, especially heart and brain diseases.

A 30-Year Look at Aging

Researchers from the Karolinska Institutet followed everyone born in Sweden between 1920 and 1922 who was still alive at age 70. Using national medical records, they tracked each person’s health from January 1, 1990, until death, their 100th birthday, or December 31, 2022 — whichever came first. That means the follow-up period was up to 30 years, not the same length for everyone.

The study, published in eClinicalMedicine, found that “disease resilience, when compared to non-centenarians, becomes apparent well before extreme old age, emerging as early as age 70.”

Long, happy life: Elderly woman with hands in the air
Resilience to disease might be the most powerful predictor of reaching 100, scientists say. (Italo Melo / pexels.com)

Centenarians Stay Healthier for Longer

From the start of the follow-up period, those destined to reach 100 consistently developed fewer health problems and experienced slower disease accumulation. At age 85, centenarians averaged just 1.2 diagnosed diseases, compared to 2.4 among people who would die at age 90.

The study found that disease accumulation remained stable in the final years of life for centenarians, whereas it continued to rise in individuals with shorter lifespans.

Centenarians were also more likely to have illnesses confined to a single disease category rather than multiple overlapping problems. For example, someone might have cardiovascular disease but no additional diagnoses from other categories, a sign of less complex health challenges.

The Big Gaps: Heart and Brain Health

Cardiovascular disease was the most common health issue across all age groups, but its share of the total disease burden was far smaller in centenarians. At age 70, heart problems made up 51.6% of all diagnoses among those who died at 75, but just 24.8% among future centenarians.

Differences were even greater for brain-related conditions. Neuropsychiatric disorders, including dementia and depression, were consistently less common in centenarians, with the study noting they showed “the largest relative difference across all ages” compared to people who died younger.

Cancer presented a different story. The authors wrote that research suggests “centenarians do not completely avoid cancer but may be able to mitigate its impact, or develop less aggressive forms of cancer. They may have greater resistance to cancer progression or respond more effectively to treatment.” That ability could stem from biological resistance, slower tumor growth, or better treatment response.

Why Prevention Matters

Because differences in disease patterns were already visible at age 70, the roots of exceptional longevity likely lie much earlier in life. Genes, lifestyle choices, and environmental exposures could all contribute to this long-term advantage.

The authors note that identifying the genetic, epigenetic, and environmental factors behind this early “disease resilience” could inform early-life preventive strategies and lead to novel interventions.

The findings also push back against assumptions that extreme longevity will always strain healthcare systems. If centenarians maintain a lower disease burden for most of their lives, they may actually require fewer medical resources than expected in their later years.

”Our results challenge the widespread belief that a longer life inevitably means more diseases. We show that centenarians follow a distinct aging curve, with slower disease progression and greater resistance to common age-related diseases,” says co-author Karin Modig, associate professor at the Institute of Environmental Medicine, Karolinska Institutet, in a statement.

The Caveats

The study’s disease data came from hospital and specialist care visits in Sweden’s National Patient Register. That means it may miss some illnesses diagnosed only in primary care or never formally recorded. Differences in how often people seek medical help could also influence the results, although Sweden’s universal healthcare likely reduced major access disparities.

Because the research looked at broad disease categories rather than individual conditions, results may not apply equally across all illnesses. And while the Swedish context offers high-quality health records, the patterns may differ in countries with other healthcare systems or population profiles.

Centenarians Experience A Different Kind of Aging

Centenarians may not owe their longevity to one or two specific characteristics or daily habits. They show distinctive health patterns that likely originate earlier in life, plausibly shaped by genetic, epigenetic, and environmental influences.

Reaching 100, in other words, isn’t just about surviving illnesses longer or winning a genetic lottery for beating diseases. Instead, it’s about delaying them, avoiding the worst overlaps, and keeping the body’s systems in balance for as long as possible.

While only about 1.6% of the study group lived to 100, understanding how they stayed healthier longer could help more people extend not just their lifespan, but their healthspan — the years lived in good health.

Disclaimer: This article is based on research findings published in a peer-reviewed medical journal. The study shows associations between disease patterns and longevity but does not prove causation. Findings apply to the Swedish population studied and may not directly translate to other countries or groups. Readers should not interpret this information as medical advice; always consult qualified healthcare professionals for personal health guidance.


Paper Summary

Methodology

Researchers analyzed data from all 274,108 individuals born in Sweden between 1920 and 1922 who were alive at age 70. Participants were tracked from January 1990 until death, 100th birthday, or December 2022 using Sweden’s National Patient Register. The study examined 40 diseases grouped into 10 categories and recorded only the first occurrence of each condition, using both primary and secondary diagnoses from hospital and specialist visits.

Results

Centenarians (1.6% of the group) had fewer diseases and slower accumulation from age 70 onward. At 85, they averaged 1.2 diseases compared to 2.4 for those dying at 90. Cardiovascular disease was common but contributed less to their total burden. Neuropsychiatric disorders showed the largest differences between groups. The overall prevalence of malignancies was lower in centenarians than in non-centenarians, though malignancies made up a relatively larger share of centenarians’ total disease burden at some ages. Disease accumulation stabilized in centenarians’ final years but continued rising in shorter-lived individuals.

Limitations

Disease identification relied on national register data, potentially underestimating prevalence. Illnesses weren’t evenly distributed across categories. Healthcare-seeking behaviors might differ. The study’s results may not translate directly to countries with different healthcare systems.

Funding & Disclosures

Supported by internal KID funding from Karolinska Institutet, the Swedish National Graduate School on Ageing and Health, and the Swedish Research Council for Health, Working Life and Welfare. Two authors report funding or board roles; the other authors declare no competing interests.

Publication Details

Title: Disease accumulation and distribution across the lifespan in Swedish centenarians and non-centenarians
Authors: Yashan Zhang, et al.
Journal: eClinicalMedicine, 87, February 2025
DOI: 10.1016/j.eclinm.2025.103396

About StudyFinds Analysis

Called "brilliant," "fantastic," and "spot on" by scientists and researchers, our acclaimed StudyFinds Analysis articles are created using an exclusive AI-based model with complete human oversight by the StudyFinds Editorial Team. For these articles, we use an unparalleled LLM process across multiple systems to analyze entire journal papers, extract data, and create accurate, accessible content. Our writing and editing team proofreads and polishes each and every article before publishing. With recent studies showing that artificial intelligence can interpret scientific research as well as (or even better) than field experts and specialists, StudyFinds was among the earliest to adopt and test this technology before approving its widespread use on our site. We stand by our practice and continuously update our processes to ensure the very highest level of accuracy. Read our AI Policy (link below) for more information.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink

Editor-in-Chief

John Anderer

Associate Editor

Leave a Comment